Viewing Study NCT02313220


Ignite Creation Date: 2025-12-25 @ 4:24 AM
Ignite Modification Date: 2026-02-11 @ 8:57 AM
Study NCT ID: NCT02313220
Status: COMPLETED
Last Update Posted: 2016-11-17
First Post: 2014-12-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Exploratory Study to Investigate the Effect of Dapagliflozin and Exenatide Combined on Body Weight
Sponsor: Uppsala University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Obesity View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Obesity View
None Dapagliflozin View
None Exenatide View
None Combination treatment View
None Type 2 diabetes View